硫酸キニジンの世界市場 (2024～2028年)

硫酸キニジン市場 (2024～2028年)

硫酸キニジン市場は2023年から2028年に2億7,260万米ドル分拡大し、予測期間中に4.5%のCAGRで成長すると予測されます。当レポートでは、硫酸キニジン市場の全体的な分析、市場規模・予測、動向、成長促進要因、課題、約25社のベンダーを網羅したベンダー分析などを掲載しています。

当レポートでは、現在の市場シナリオ、最新動向と促進要因、市場環境全体に関する最新分析を提供しています。マラリア罹患率の増加、堅調なパイプラインと医薬品承認、ベンダーによる合併・買収の増加が市場を牽引しています。

当レポートでは、今後数年間の硫酸キニジン市場の成長を促進する主な理由の一つとして、マラリア撲滅のための強力な資金調達を挙げています。また、不整脈の発生率の増加や硫酸キニジン・サプリメントに対する人々の意識の高まりは、市場の大きな需要につながります。

目次

第1章 エグゼクティブサマリー

• 市場概要

第2章 市場情勢

• 市場エコシステム
• 市場の特徴
• バリューチェーン分析

第3章 市場規模の評価

• 市場の定義
• 市場セグメント分析
• 市場規模 (2023年)
• 市場の見通し (2023～2028年)

第4章 市場規模実績

• 硫酸キニジンの世界市場 (2018～2022年)
• 疾患の種類別の分析 (2018～2022年)
• 地域別分析 (2018～2022年)
• 国別分析 (2018～2022年)

第5章 ファイブフォース分析

• ファイブフォースの要約
• 買い手の交渉力
• 供給企業の交渉力
• 新規参入業者の脅威
• 代替品の脅威
• 競争の脅威
• 市況

第6章 市場セグメンテーション：疾患の種類別

• 市場セグメンテーション
• 比較：疾患の種類別
• マラリア：市場規模と予測 (2023～2028年)
• 不整脈：市場規模と予測 (2023～2028年)
• 疾患の種類別の市場機会

第7章 顧客情勢

• 顧客情勢の概要

第8章 地域別情勢

• 地域別セグメンテーション
• 地域別比較
• 北米：市場規模と予測 (2023～2028年)
• 欧州：市場規模と予測 (2023～2028年)
• アジア：市場規模と予測 (2023～2028年)
• 世界のその他の地域：市場規模と予測 (2023～2028年)
• 米国：市場規模と予測 (2023～2028年)
• ドイツ：市場規模と予測 (2023～2028年)
• 中国：市場規模と予測 (2023～2028年)
• 英国：市場規模と予測 (2023～2028年)
• カナダ：市場規模と予測 (2023～2028年)
• 地域別の市場機会

第9章 促進要因・課題・機会・抑制要因

• 市場促進要因
• 市場の課題
• 促進要因と課題の影響
• 市場の機会・抑制要因

第10章 競合情勢

• 概要
• 競合情勢
• 混乱の状況
• 業界のリスク

第11章 競合分析

• 企業プロファイル
• 企業の市場ポジショニング
• Bennet Pharmaceuticals Ltd.
• Buchler GmbH
• Cipla Inc.
• Ipca Laboratories
• Lark Laboratories India Ltd.
• Merck and Co. Inc.
• PMC Group Inc.
• PRISM INDUSTRIES PVT. LTD.
• Teva Pharmaceutical Industries Ltd.
• VIVAN Life Sciences Pvt. Ltd.

第12章 付録

Exhibits:

• Exhibits1: Executive Summary - Chart on Market Overview
• Exhibits2: Executive Summary - Data Table on Market Overview
• Exhibits3: Executive Summary - Chart on Global Market Characteristics
• Exhibits4: Executive Summary - Chart on Market By Geographical Landscape
• Exhibits5: Executive Summary - Chart on Market Segmentation by Disease Type
• Exhibits6: Executive Summary - Chart on Incremental Growth
• Exhibits7: Executive Summary - Data Table on Incremental Growth
• Exhibits8: Executive Summary - Chart on Company Market Positioning
• Exhibits9: Parent Market
• Exhibits10: Data Table on - Parent Market
• Exhibits11: Market characteristics analysis
• Exhibits12: Value Chain Analysis
• Exhibits13: Offerings of companies included in the market definition
• Exhibits14: Market segments
• Exhibits15: Chart on Global - Market size and forecast 2023-2028 ($ million)
• Exhibits16: Data Table on Global - Market size and forecast 2023-2028 ($ million)
• Exhibits17: Chart on Global Market: Year-over-year growth 2023-2028 (%)
• Exhibits18: Data Table on Global Market: Year-over-year growth 2023-2028 (%)
• Exhibits19: Historic Market Size - Data Table on Global Quinidine Sulfate Market 2018 - 2022 ($ million)
• Exhibits20: Historic Market Size - Disease Type Segment 2018 - 2022 ($ million)
• Exhibits21: Historic Market Size - Geography Segment 2018 - 2022 ($ million)
• Exhibits22: Historic Market Size - Country Segment 2018 - 2022 ($ million)
• Exhibits23: Five forces analysis - Comparison between 2023 and 2028
• Exhibits24: Bargaining power of buyers - Impact of key factors 2023 and 2028
• Exhibits25: Bargaining power of suppliers - Impact of key factors in 2023 and 2028
• Exhibits26: Threat of new entrants - Impact of key factors in 2023 and 2028
• Exhibits27: Threat of substitutes - Impact of key factors in 2023 and 2028
• Exhibits28: Threat of rivalry - Impact of key factors in 2023 and 2028
• Exhibits29: Chart on Market condition - Five forces 2023 and 2028
• Exhibits30: Chart on Disease Type - Market share 2023-2028 (%)
• Exhibits31: Data Table on Disease Type - Market share 2023-2028 (%)
• Exhibits32: Chart on Comparison by Disease Type
• Exhibits33: Data Table on Comparison by Disease Type
• Exhibits34: Chart on Malaria - Market size and forecast 2023-2028 ($ million)
• Exhibits35: Data Table on Malaria - Market size and forecast 2023-2028 ($ million)
• Exhibits36: Chart on Malaria - Year-over-year growth 2023-2028 (%)
• Exhibits37: Data Table on Malaria - Year-over-year growth 2023-2028 (%)
• Exhibits38: Chart on Arrhythmias - Market size and forecast 2023-2028 ($ million)
• Exhibits39: Data Table on Arrhythmias - Market size and forecast 2023-2028 ($ million)
• Exhibits40: Chart on Arrhythmias - Year-over-year growth 2023-2028 (%)
• Exhibits41: Data Table on Arrhythmias - Year-over-year growth 2023-2028 (%)
• Exhibits42: Market opportunity by Disease Type ($ million)
• Exhibits43: Data Table on Market opportunity by Disease Type ($ million)
• Exhibits44: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
• Exhibits45: Chart on Market share By Geographical Landscape 2023-2028 (%)
• Exhibits46: Data Table on Market share By Geographical Landscape 2023-2028 (%)
• Exhibits47: Chart on Geographic comparison
• Exhibits48: Data Table on Geographic comparison
• Exhibits49: Chart on North America - Market size and forecast 2023-2028 ($ million)
• Exhibits50: Data Table on North America - Market size and forecast 2023-2028 ($ million)
• Exhibits51: Chart on North America - Year-over-year growth 2023-2028 (%)
• Exhibits52: Data Table on North America - Year-over-year growth 2023-2028 (%)
• Exhibits53: Chart on Europe - Market size and forecast 2023-2028 ($ million)
• Exhibits54: Data Table on Europe - Market size and forecast 2023-2028 ($ million)
• Exhibits55: Chart on Europe - Year-over-year growth 2023-2028 (%)
• Exhibits56: Data Table on Europe - Year-over-year growth 2023-2028 (%)
• Exhibits57: Chart on Asia - Market size and forecast 2023-2028 ($ million)
• Exhibits58: Data Table on Asia - Market size and forecast 2023-2028 ($ million)
• Exhibits59: Chart on Asia - Year-over-year growth 2023-2028 (%)
• Exhibits60: Data Table on Asia - Year-over-year growth 2023-2028 (%)
• Exhibits61: Chart on Rest of World (ROW) - Market size and forecast 2023-2028 ($ million)
• Exhibits62: Data Table on Rest of World (ROW) - Market size and forecast 2023-2028 ($ million)
• Exhibits63: Chart on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
• Exhibits64: Data Table on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
• Exhibits65: Chart on US - Market size and forecast 2023-2028 ($ million)
• Exhibits66: Data Table on US - Market size and forecast 2023-2028 ($ million)
• Exhibits67: Chart on US - Year-over-year growth 2023-2028 (%)
• Exhibits68: Data Table on US - Year-over-year growth 2023-2028 (%)
• Exhibits69: Chart on Germany - Market size and forecast 2023-2028 ($ million)
• Exhibits70: Data Table on Germany - Market size and forecast 2023-2028 ($ million)
• Exhibits71: Chart on Germany - Year-over-year growth 2023-2028 (%)
• Exhibits72: Data Table on Germany - Year-over-year growth 2023-2028 (%)
• Exhibits73: Chart on China - Market size and forecast 2023-2028 ($ million)
• Exhibits74: Data Table on China - Market size and forecast 2023-2028 ($ million)
• Exhibits75: Chart on China - Year-over-year growth 2023-2028 (%)
• Exhibits76: Data Table on China - Year-over-year growth 2023-2028 (%)
• Exhibits77: Chart on UK - Market size and forecast 2023-2028 ($ million)
• Exhibits78: Data Table on UK - Market size and forecast 2023-2028 ($ million)
• Exhibits79: Chart on UK - Year-over-year growth 2023-2028 (%)
• Exhibits80: Data Table on UK - Year-over-year growth 2023-2028 (%)
• Exhibits81: Chart on Canada - Market size and forecast 2023-2028 ($ million)
• Exhibits82: Data Table on Canada - Market size and forecast 2023-2028 ($ million)
• Exhibits83: Chart on Canada - Year-over-year growth 2023-2028 (%)
• Exhibits84: Data Table on Canada - Year-over-year growth 2023-2028 (%)
• Exhibits85: Market opportunity By Geographical Landscape ($ million)
• Exhibits86: Data Tables on Market opportunity By Geographical Landscape ($ million)
• Exhibits87: Impact of drivers and challenges in 2023 and 2028
• Exhibits88: Overview on criticality of inputs and factors of differentiation
• Exhibits89: Overview on factors of disruption
• Exhibits90: Impact of key risks on business
• Exhibits91: Companies covered
• Exhibits92: Matrix on companies position and classification
• Exhibits93: Bennet Pharmaceuticals Ltd. - Overview
• Exhibits94: Bennet Pharmaceuticals Ltd. - Product / Service
• Exhibits95: Bennet Pharmaceuticals Ltd. - Key offerings
• Exhibits96: Buchler GmbH - Overview
• Exhibits97: Buchler GmbH - Product / Service
• Exhibits98: Buchler GmbH - Key offerings
• Exhibits99: Cipla Inc. - Overview
• Exhibits100: Cipla Inc. - Business segments
• Exhibits101: Cipla Inc. - Key news
• Exhibits102: Cipla Inc. - Key offerings
• Exhibits103: Cipla Inc. - Segment focus
• Exhibits104: Ipca Laboratories - Overview
• Exhibits105: Ipca Laboratories - Product / Service
• Exhibits106: Ipca Laboratories - Key offerings
• Exhibits107: Lark Laboratories India Ltd. - Overview
• Exhibits108: Lark Laboratories India Ltd. - Product / Service
• Exhibits109: Lark Laboratories India Ltd. - Key offerings
• Exhibits110: Merck and Co. Inc. - Overview
• Exhibits111: Merck and Co. Inc. - Business segments
• Exhibits112: Merck and Co. Inc. - Key news
• Exhibits113: Merck and Co. Inc. - Key offerings
• Exhibits114: Merck and Co. Inc. - Segment focus
• Exhibits115: PMC Group Inc. - Overview
• Exhibits116: PMC Group Inc. - Product / Service
• Exhibits117: PMC Group Inc. - Key offerings
• Exhibits118: PRISM INDUSTRIES PVT. LTD. - Overview
• Exhibits119: PRISM INDUSTRIES PVT. LTD. - Product / Service
• Exhibits120: PRISM INDUSTRIES PVT. LTD. - Key offerings
• Exhibits121: Teva Pharmaceutical Industries Ltd. - Overview
• Exhibits122: Teva Pharmaceutical Industries Ltd. - Business segments
• Exhibits123: Teva Pharmaceutical Industries Ltd. - Key news
• Exhibits124: Teva Pharmaceutical Industries Ltd. - Key offerings
• Exhibits125: Teva Pharmaceutical Industries Ltd. - Segment focus
• Exhibits126: VIVAN Life Sciences Pvt. Ltd. - Overview
• Exhibits127: VIVAN Life Sciences Pvt. Ltd. - Product / Service
• Exhibits128: VIVAN Life Sciences Pvt. Ltd. - Key offerings
• Exhibits129: Inclusions checklist
• Exhibits130: Exclusions checklist
• Exhibits131: Currency conversion rates for US$
• Exhibits132: Research methodology
• Exhibits133: Information sources
• Exhibits134: Data validation
• Exhibits135: Validation techniques employed for market sizing
• Exhibits136: Data synthesis
• Exhibits137: 360 degree market analysis
• Exhibits138: List of abbreviations

Quinidine Sulfate Market 2024-2028

The quinidine sulfate market is forecasted to grow by USD 272.6 mn during 2023-2028, accelerating at a CAGR of 4.5% during the forecast period. The report on the quinidine sulfate market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.

The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by growing incidence of malaria, robust pipeline and drug approvals, and increasing mergers and acquisitions by market vendors.

Technavio's quinidine sulfate market is segmented as below:

By Disease Type

• Malaria
• Arrhythmias

By Geographical Landscape

• North America
• Europe
• Asia
• Rest of World (ROW)

This study identifies the strong funding for eradication of malaria as one of the prime reasons driving the quinidine sulfate market growth during the next few years. Also, increase in incidence of arrhythmia and increasing awareness among people about quinidine sulfate supplements will lead to sizable demand in the market.

The report on the quinidine sulfate market covers the following areas:

• Quinidine Sulfate Market sizing
• Quinidine Sulfate Market forecast
• Quinidine Sulfate Market industry analysis

The robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading quinidine sulfate market vendors that include Bennet Pharmaceuticals Ltd., Biophore India Pharmaceuticals Pvt. Ltd., Buchler GmbH, Cipla Inc., Inga Laboratories P. Ltd., Ipca Laboratories, Koninklijke DSM NV, Lark Laboratories India Ltd., Merck and Co. Inc., PMC Group Inc., PRISM INDUSTRIES PVT. LTD., PT Bio Farma, PT Sinkona Indonesia lestar, Teva Pharmaceutical Industries Ltd., Vital Laboratories Pvt. Ltd., and VIVAN Life Sciences Pvt. Ltd.. Also, the quinidine sulfate market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.

The publisher presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive primary and secondary research. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast accurate market growth.

Table of Contents

1 Executive Summary

• 1.1 Market overview
  • Executive Summary - Chart on Market Overview
  • Executive Summary - Data Table on Market Overview
  • Executive Summary - Chart on Global Market Characteristics
  • Executive Summary - Chart on Market By Geographical Landscape
  • Executive Summary - Chart on Market Segmentation by Disease Type
  • Executive Summary - Chart on Incremental Growth
  • Executive Summary - Data Table on Incremental Growth
  • Executive Summary - Chart on Company Market Positioning

2 Market Landscape

• 2.1 Market ecosystem
  • Parent Market
  • Data Table on - Parent Market
• 2.2 Market characteristics
  • Market characteristics analysis
• 2.3 Value chain analysis
  • Value Chain Analysis

3 Market Sizing

• 3.1 Market definition
  • Offerings of companies included in the market definition
• 3.2 Market segment analysis
  • Market segments
• 3.3 Market size 2023
• 3.4 Market outlook: Forecast for 2023-2028
  • Chart on Global - Market size and forecast 2023-2028 ($ million)
  • Data Table on Global - Market size and forecast 2023-2028 ($ million)
  • Chart on Global Market: Year-over-year growth 2023-2028 (%)
  • Data Table on Global Market: Year-over-year growth 2023-2028 (%)

4 Historic Market Size

• 4.1 Global Quinidine Sulfate Market 2018 - 2022
  • Historic Market Size - Data Table on Global Quinidine Sulfate Market 2018 - 2022 ($ million)
• 4.2 Disease Type segment analysis 2018 - 2022
  • Historic Market Size - Disease Type Segment 2018 - 2022 ($ million)
• 4.3 Geography segment analysis 2018 - 2022
  • Historic Market Size - Geography Segment 2018 - 2022 ($ million)
• 4.4 Country segment analysis 2018 - 2022
  • Historic Market Size - Country Segment 2018 - 2022 ($ million)

5 Five Forces Analysis

• 5.1 Five forces summary
  • Five forces analysis - Comparison between 2023 and 2028
• 5.2 Bargaining power of buyers
  • Bargaining power of buyers - Impact of key factors 2023 and 2028
• 5.3 Bargaining power of suppliers
  • Bargaining power of suppliers - Impact of key factors in 2023 and 2028
• 5.4 Threat of new entrants
  • Threat of new entrants - Impact of key factors in 2023 and 2028
• 5.5 Threat of substitutes
  • Threat of substitutes - Impact of key factors in 2023 and 2028
• 5.6 Threat of rivalry
  • Threat of rivalry - Impact of key factors in 2023 and 2028
• 5.7 Market condition
  • Chart on Market condition - Five forces 2023 and 2028

6 Market Segmentation by Disease Type

• 6.1 Market segments
  • Chart on Disease Type - Market share 2023-2028 (%)
  • Data Table on Disease Type - Market share 2023-2028 (%)
• 6.2 Comparison by Disease Type
  • Chart on Comparison by Disease Type
  • Data Table on Comparison by Disease Type
• 6.3 Malaria - Market size and forecast 2023-2028
  • Chart on Malaria - Market size and forecast 2023-2028 ($ million)
  • Data Table on Malaria - Market size and forecast 2023-2028 ($ million)
  • Chart on Malaria - Year-over-year growth 2023-2028 (%)
  • Data Table on Malaria - Year-over-year growth 2023-2028 (%)
• 6.4 Arrhythmias - Market size and forecast 2023-2028
  • Chart on Arrhythmias - Market size and forecast 2023-2028 ($ million)
  • Data Table on Arrhythmias - Market size and forecast 2023-2028 ($ million)
  • Chart on Arrhythmias - Year-over-year growth 2023-2028 (%)
  • Data Table on Arrhythmias - Year-over-year growth 2023-2028 (%)
• 6.5 Market opportunity by Disease Type
  • Market opportunity by Disease Type ($ million)
  • Data Table on Market opportunity by Disease Type ($ million)

7 Customer Landscape

• 7.1 Customer landscape overview
  • Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria

8 Geographic Landscape

• 8.1 Geographic segmentation
  • Chart on Market share By Geographical Landscape 2023-2028 (%)
  • Data Table on Market share By Geographical Landscape 2023-2028 (%)
• 8.2 Geographic comparison
  • Chart on Geographic comparison
  • Data Table on Geographic comparison
• 8.3 North America - Market size and forecast 2023-2028
  • Chart on North America - Market size and forecast 2023-2028 ($ million)
  • Data Table on North America - Market size and forecast 2023-2028 ($ million)
  • Chart on North America - Year-over-year growth 2023-2028 (%)
  • Data Table on North America - Year-over-year growth 2023-2028 (%)
• 8.4 Europe - Market size and forecast 2023-2028
  • Chart on Europe - Market size and forecast 2023-2028 ($ million)
  • Data Table on Europe - Market size and forecast 2023-2028 ($ million)
  • Chart on Europe - Year-over-year growth 2023-2028 (%)
  • Data Table on Europe - Year-over-year growth 2023-2028 (%)
• 8.5 Asia - Market size and forecast 2023-2028
  • Chart on Asia - Market size and forecast 2023-2028 ($ million)
  • Data Table on Asia - Market size and forecast 2023-2028 ($ million)
  • Chart on Asia - Year-over-year growth 2023-2028 (%)
  • Data Table on Asia - Year-over-year growth 2023-2028 (%)
• 8.6 Rest of World (ROW) - Market size and forecast 2023-2028
  • Chart on Rest of World (ROW) - Market size and forecast 2023-2028 ($ million)
  • Data Table on Rest of World (ROW) - Market size and forecast 2023-2028 ($ million)
  • Chart on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
  • Data Table on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
• 8.7 US - Market size and forecast 2023-2028
  • Chart on US - Market size and forecast 2023-2028 ($ million)
  • Data Table on US - Market size and forecast 2023-2028 ($ million)
  • Chart on US - Year-over-year growth 2023-2028 (%)
  • Data Table on US - Year-over-year growth 2023-2028 (%)
• 8.8 Germany - Market size and forecast 2023-2028
  • Chart on Germany - Market size and forecast 2023-2028 ($ million)
  • Data Table on Germany - Market size and forecast 2023-2028 ($ million)
  • Chart on Germany - Year-over-year growth 2023-2028 (%)
  • Data Table on Germany - Year-over-year growth 2023-2028 (%)
• 8.9 China - Market size and forecast 2023-2028
  • Chart on China - Market size and forecast 2023-2028 ($ million)
  • Data Table on China - Market size and forecast 2023-2028 ($ million)
  • Chart on China - Year-over-year growth 2023-2028 (%)
  • Data Table on China - Year-over-year growth 2023-2028 (%)
• 8.10 UK - Market size and forecast 2023-2028
  • Chart on UK - Market size and forecast 2023-2028 ($ million)
  • Data Table on UK - Market size and forecast 2023-2028 ($ million)
  • Chart on UK - Year-over-year growth 2023-2028 (%)
  • Data Table on UK - Year-over-year growth 2023-2028 (%)
• 8.11 Canada - Market size and forecast 2023-2028
  • Chart on Canada - Market size and forecast 2023-2028 ($ million)
  • Data Table on Canada - Market size and forecast 2023-2028 ($ million)
  • Chart on Canada - Year-over-year growth 2023-2028 (%)
  • Data Table on Canada - Year-over-year growth 2023-2028 (%)
• 8.12 Market opportunity By Geographical Landscape
  • Market opportunity By Geographical Landscape ($ million)
  • Data Tables on Market opportunity By Geographical Landscape ($ million)

9 Drivers, Challenges, and Opportunity/Restraints

• 9.1 Market drivers
• 9.2 Market challenges
• 9.3 Impact of drivers and challenges
  • Impact of drivers and challenges in 2023 and 2028
• 9.4 Market opportunities/restraints

10 Competitive Landscape

• 10.1 Overview
• 10.2 Competitive Landscape
  • Overview on criticality of inputs and factors of differentiation
• 10.3 Landscape disruption
  • Overview on factors of disruption
• 10.4 Industry risks
  • Impact of key risks on business

11 Competitive Analysis

• 11.1 Companies profiled
  • Companies covered
• 11.2 Market positioning of companies
  • Matrix on companies position and classification
• 11.3 Bennet Pharmaceuticals Ltd.
  • Bennet Pharmaceuticals Ltd. - Overview
  • Bennet Pharmaceuticals Ltd. - Product / Service
  • Bennet Pharmaceuticals Ltd. - Key offerings
• 11.4 Buchler GmbH
  • Buchler GmbH - Overview
  • Buchler GmbH - Product / Service
  • Buchler GmbH - Key offerings
• 11.5 Cipla Inc.
  • Cipla Inc. - Overview
  • Cipla Inc. - Business segments
  • Cipla Inc. - Key news
  • Cipla Inc. - Key offerings
  • Cipla Inc. - Segment focus
• 11.6 Ipca Laboratories
  • Ipca Laboratories - Overview
  • Ipca Laboratories - Product / Service
  • Ipca Laboratories - Key offerings
• 11.7 Lark Laboratories India Ltd.
  • Lark Laboratories India Ltd. - Overview
  • Lark Laboratories India Ltd. - Product / Service
  • Lark Laboratories India Ltd. - Key offerings
• 11.8 Merck and Co. Inc.
  • Merck and Co. Inc. - Overview
  • Merck and Co. Inc. - Business segments
  • Merck and Co. Inc. - Key news
  • Merck and Co. Inc. - Key offerings
  • Merck and Co. Inc. - Segment focus
• 11.9 PMC Group Inc.
  • PMC Group Inc. - Overview
  • PMC Group Inc. - Product / Service
  • PMC Group Inc. - Key offerings
• 11.10 PRISM INDUSTRIES PVT. LTD.
  • PRISM INDUSTRIES PVT. LTD. - Overview
  • PRISM INDUSTRIES PVT. LTD. - Product / Service
  • PRISM INDUSTRIES PVT. LTD. - Key offerings
• 11.11 Teva Pharmaceutical Industries Ltd.
  • Teva Pharmaceutical Industries Ltd. - Overview
  • Teva Pharmaceutical Industries Ltd. - Business segments
  • Teva Pharmaceutical Industries Ltd. - Key news
  • Teva Pharmaceutical Industries Ltd. - Key offerings
  • Teva Pharmaceutical Industries Ltd. - Segment focus
• 11.12 VIVAN Life Sciences Pvt. Ltd.
  • VIVAN Life Sciences Pvt. Ltd. - Overview
  • VIVAN Life Sciences Pvt. Ltd. - Product / Service
  • VIVAN Life Sciences Pvt. Ltd. - Key offerings

12 Appendix

• 12.1 Scope of the report
• 12.2 Inclusions and exclusions checklist
  • Inclusions checklist
  • Exclusions checklist
• 12.3 Currency conversion rates for US$
  • Currency conversion rates for US$
• 12.4 Research methodology
  • Research methodology
• 12.5 Data procurement
  • Information sources
• 12.6 Data validation
  • Data validation
• 12.7 Validation techniques employed for market sizing
  • Validation techniques employed for market sizing
• 12.8 Data synthesis
  • Data synthesis
• 12.9 360 degree market analysis
  • 360 degree market analysis
• 12.10 List of abbreviations
  • List of abbreviations